-
No More YouTube on Science & Enterprise
Because YouTube’s business model relies on luring viewers to content unrelated to our stories, including videos that we abhor, Science & Enterprise will no longer embed or link to YouTube videos.
-
Foundation Supports Muscular Dystrophy RNA Therapy
A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy.
-
Intermountain, deCode Partner on Population Genetics
A health care network in Utah is partnering with a genetic analytics company to find connections between genetics and disease in 500,000 of its members.
-
Antibiotics Synthesized from Scorpion Venom
Biochemistry labs in the U.S. and Mexico isolated and synthesized key compounds from scorpion venom that kills bacteria resistant to antibiotics.
-
Patch Performs Fast DNA Collection for Plant Diseases
A small patch with tiny needles collects DNA from leaves in about one minute, making possible portable devices to detect plant diseases.
-
DoD Funding Vaccine, Therapy Delivery Device
The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin.
-
Engineered Antibody Delays Type 1 Diabetes Onset
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease.
-
Infographic – China’s Rare Earth Monopoly Slipping
China remains the largest producer of rare earths, but other countries are developing their sources of these materials, this weekend’s infographic.
-
Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease
Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis.
-
Taking a Break
We’ll resume our regular posting on Monday 10 June, with contributed posts filling in on some days.